Vancomycin usage in central venous catheters in a neonatal intensive care unit

Pediatric Infectious Disease Journal

Volumn 23, Issue 3, 2004, Pages 201-206

  Elhassan, Nahed O ^a   Stevens, Timothy P ^a   Gigliotti, Francis ^a   Hardy, Dwight J ^b   Cole, Carol A ^b   Sinkin, Robert A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Central venous catheter infections; Percutaneous central venous catheter; Prophylaxis; Therapy; Vancomycin

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CENTRAL VENOUS CATHETERIZATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG INDICATION; DRUG USE; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MALE; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 1542514022     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000114907.13300.86     Document Type: Article

References (17)

1. Chathas MK, Paton JB, Fisher DE. Percutaneous central venous catheterization, three years' experience in a neonatal intensive care unit. Am J Dis Child 1990;144:1246-50.
2. Ogata ES, Schulman S, Raffensperger J, Luck S, Rusnak M. Caval catherization in the intensive care nursery: a useful means of providing parenteral nutrition to the extremely low birth-weight infant. J Pediatr Surg 1984;19:258-62.
3. Warner BW, Gorgone P, Schilling S, Farrell M, Ghory MJ. Multiple-purpose central venous access in infants less than 1,000 grams. J Pediatr Surg 1987;22:820-2.
4. Nataro JP, Corcoran L, Zirin S, et al. Prospective analysis of coagulase-negative staphylococcal infection in hospitalized infants. J Pediatr 1994;125:798-804.
5. St. Geme JW, Harris MC. Coagulase-negative staphylococcal infection in the neonate. Clin Perinatol 1992;18:281-302.
6. Schmidt BK, Kirpalani HM, Corey M, Low DE, Philip AGS, Ford-Jones EL. Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study. Pediatr Infect Dis J 1987;6:1026-31.
7. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter related coagulase negative staphylococcal sepsis in neonates. J Pediatr 1994;125:259-63.
8. Cooke RWI, Nycyk JA, Okuonghuae H, Shah V, Damjanovic V, Hart CA. Low dose vancomycin prophylaxis reduces coagulase negative staphylococcal bacteraemia in very low birth-weight infants. J Hosp Infect 1997;37:297-303.
9. Baier RJ, Bocchini JA, Brown EG. Selective use of vancomycin to prevent coagulase negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr Infect Dis J 1998;17:179-83.
10. Moller JC, Nachtrodt G, Tegtmeyer FK, Richter A, Gortner L. Prophylactic low-dose vancomycin treatment in very-low-birth-weight infants. Dev Pharmacol Ther 1992;19:178-92.
11. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of Gram positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994;125:253-8.
12. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR 1993;42:597-9.
13. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in NY City. Lancet 1993;342:76-9.
14. Anonymous. Recommendations and reports. MMWR 2002;51(RR-10-1):27-8.
15. Vancomycin for prophylaxis against sepsis in preterm infants. The Cochrane Library. Issue 4, 2002.
16. Viscoli C, Moroni C, Boni L, et al. Ceftazidime plus amikacin vs. ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer. Rev Infect Dis 1991;13:397-404.
17. Van Houten MA, Uiterwaal CS, Heesen GJ, Arends JP, Kimpen JL. Does the empiric use of vancomycin in pediatric increase the risk for Gram-negative bacteremia? Pediatr Infect Dis J 2001;20:171-7.